.png)
Cite this article as: Satoh H, Miyazaki K, Sato Y, Hizawa N. Response to afatinib in a common EGFR-mutated lung adenocarcinoma with a very rare combination of compound mutations. Turk Thorac J. 2022;23(5):364-365.
Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba
2.Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital
3.DNA Chip Research Inc. (Tokyo, Japan)
4.Division of Respiratory Medicine, Faculty of Clinical Medicine, University of Tsukuba
Cite this article as: Satoh H, Miyazaki K, Sato Y, Hizawa N. Response to afatinib in a common EGFR-mutated lung adenocarcinoma with a very rare combination of compound mutations. Turk Thorac J. 2022;23(5):364-365.